RBF Capital’s SkinHealth Systems SKIN Stock Holding History

RBF Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,500	Closed	-$379K	–	541
2023 Q1	$379K	Buy	+1,500	New	+$347K	0.03%	382

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RBF Capital's SKIN Position: Q2 2023 in Review

RBF Capital sold out of SkinHealth Systems (SKIN) in Q2 2023, closing a stake of 1,500 shares — an estimated $379K sold.

RBF Capital first reported a position in SKIN in Q1 2023 and held it in 1 quarter. The position peaked at $379K in Q1 2023. 135 funds tracked by Wall St. Rank hold SKIN as of Q2 2023.

RBF Capital reported no remaining SkinHealth Systems position as of Q2 2023 after selling out during the quarter.
RBF Capital sold 1,500 SkinHealth Systems shares in Q2 2023, an estimated $379K.
RBF Capital first reported a position in SkinHealth Systems in Q1 2023 and held it in 1 quarter.
RBF Capital's SkinHealth Systems position peaked at $379K in Q1 2023.
135 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2023.

Based on RBF Capital's 13F filing for Q2 2023, filed 14 Aug 2023.